Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages

Journal of Nutritional Biochemistry

Volumn 23, Issue 10, 2012, Pages 1271-1276

  Ku, Chai Siah ^a   Park, Youngki ^a   Coleman, Sara L ^b   Lee, Jiyoung ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

ABCA1; ABCG1; Fatty acids; RAW 264.7 macrophage

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; HISTONE DEACETYLASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MESSENGER RNA; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN KINASE C; UNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC DISORDER; HISTONE ACETYLATION; MACROPHAGE; MOUSE; NONHUMAN;

ACETOPHENONES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BENZOPYRANS; CELL LINE, TUMOR; CHOLESTEROL; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION; HYDROCARBONS, FLUORINATED; LIPOPROTEINS; MACROPHAGES; MICE; ORPHAN NUCLEAR RECEPTORS; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SULFONAMIDES; TRANSFECTION;

EID: 84866321860     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.07.007     Document Type: Article

References (61)

1. Barr D.P., Russ E.M., Eder H.A. Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am J Med 1951, 11:480-493.
2. Miller N.E. The evidence for the antiatherogenicity of high density lipoprotein in man. Lipids 1978, 13:914-919.
3. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977, 62:707-714.
4. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989, 79:8-15.
5. Stein O., Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis 1999, 144:285-301.
6. Mauerer R., Ebert S., Langmann T. High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp Mol Med 2009, 41:126-132.
7. Glomset J.A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968, 9:155-167.
8. Pieters M.N., Schouten D., Van Berkel T.J. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim Biophys Acta 1994, 1225:125-134.
9. Francone O.L., Gong E.L., Ng D.S., Fielding C.J., Rubin E.M. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism. J Clin Invest 1995, 96:1440-1448.
10. Lacko A.G., Pritchard P.H. International symposium on reverse cholesterol transport. Report on a meeting. J Lipid Res 1990, 31:2295-2299.
11. Kusuhara H., Sugiyama Y. ATP-binding cassette, subfamily G (ABCG family). Pflugers Arch 2007, 453:735-744.
12. Ohashi R., Mu H., Wang X., Yao Q., Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 2005, 98:845-856.
13. Rogler G., Trumbach B., Klima B., Lackner K.J., Schmitz G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol 1995, 15:683-690.
14. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 1995, 96:78-87.
15. Wang N., Lan D., Chen W., Matsuura F., Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004, 101:9774-9779.
16. Klucken J., Buchler C., Orso E., Kaminski W.E., Porsch-Ozcurumez M., Liebisch G., et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci U S A 2000, 97:817-822.
17. Out R., Hoekstra M., Hildebrand R.B., Kruit J.K., Meurs I., Li Z., et al. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2006, 26:2295-2300.
18. Baldan A., Pei L., Lee R., Tarr P., Tangirala R.K., Weinstein M.M., et al. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow. Arterioscler Thromb Vasc Biol 2006, 26:2301-2307.
19. Francone O.L., Royer L., Boucher G., Haghpassand M., Freeman A., Brees D., et al. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler Thromb Vasc Biol 2005, 25:1198-1205.
20. Kennedy M.A., Barrera G.C., Nakamura K., Baldan A., Tarr P., Fishbein M.C., et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metabolism 2005, 1:121-131.
21. Out R., Jessup W., Le Goff W., Hoekstra M., Gelissen I.C., Zhao Y., et al. Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1. Circ Res 2008, 102:113-120.
22. Yvan-Charvet L., Ranalletta M., Wang N., Han S., Terasaka N., Li R., et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 2007, 117:3900-3908.
23. Haghpassand M., Bourassa P.A., Francone O.L., Aiello R.J. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 2001, 108:1315-1320.
24. Tarling EJ, Bojanic DD, Tangirala RK, Wang X, Lovgren-Sandblom A, Lusis AJ, et al. Impaired development of atherosclerosis in Abcg1-/- Apoe-/- mice: identification of specific oxysterols that both accumulate in Abcg1-/- Apoe-/- tissues and induce apoptosis. Arterioscler Thromb Vasc Biol 30:1174-80.
25. Naik S.U., Wang X., Da Silva J.S., Jaye M., Macphee C.H., Reilly M.P., et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006, 113:90-97.
26. Wang Y., Kurdi-Haidar B., Oram J.F. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J Lipid Res 2004, 45:972-980.
27. Wang Y., Oram J.F. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 2002, 277:5692-5697.
28. Wang Y., Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J Biol Chem 2005, 280:35896-35903.
29. Wang Y., Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J Lipid Res 2007, 48:1062-1068.
30. Uehara Y., Engel T., Li Z., Goepfert C., Rust S., Zhou X., et al. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 2002, 51:2922-2928.
31. Uehara Y., Miura S.i., von Eckardstein A., Abe S., Fujii A., Matsuo Y., et al. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2007, 191:11-21.
32. Park Y.K., Rasmussen H.E., Ehler S.J., Blobaum K.R., Lu F., Schlegel V.L., et al. Repression of proinflammatory gene expression by lipid extract of Nostoc commune var sphaeroides Kutzing, a blue-green alga, via inhibition of nuclear factor-kappa B in RAW 264.7 macrophages. Nutr Res 2008, 28:83-92.
33. Rasmussen H.E., Blobaum K.R., Park Y.K., Ehlers S.J., Lu F., Lee J.Y. Lipid extract of Nostoc commune var. sphaeroides Kutzing, a blue-green alga, inhibits the activation of sterol regulatory element binding proteins in HepG2 cells. J Nutr 2008, 138:476-481.
34. Boden G., Chen X., Ruiz J., White J.V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994, 93:2438-2446.
35. McGarry J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992, 258:766-770.
36. Reaven G.M., Hollenbeck C., Jeng C.Y., Wu M.S., Chen Y.D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988, 37:1020-1024.
37. Perseghin G., Ghosh S., Gerow K., Shulman G.I. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 1997, 46:1001-1009.
38. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106:171-176.
39. Ecker J., Langmann T., Moehle C., Schmitz G. Isomer specific effects of conjugated linoleic acid on macrophage ABCG1 transcription by a SREBP-1c dependent mechanism. Biochem Biophys Res Commun 2007, 352:805-811.
40. Murthy S., Born E., Mathur S.N., Field F.J. Liver-X-receptor-mediated increase in ATP-binding cassette transporter A1 expression is attenuated by fatty acids in CaCo-2 cells: effect on cholesterol efflux to high-density lipoprotein. Biochem J 2004, 377:545-552.
41. Wagner B.L., Valledor A.F., Shao G., Daige C.L., Bischoff E.D., Petrowski M., et al. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol 2003, 23:5780-5789.
42. Li A.C., Binder C.J., Gutierrez A., Brown K.K., Plotkin C.R., Pattison J.W., et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 2004, 114:1564-1576.
43. Zhang J., Kalkum M., Chait B.T., Roeder R.G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 2002, 9:611-623.
44. Perissi V., Aggarwal A., Glass C.K., Rose D.W., Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004, 116:511-526.
45. Lee S.K., Kim J.H., Lee Y.C., Cheong J., Lee J.W. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J Biol Chem 2000, 275:12470-12474.
46. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 2002, 110:55-67.
47. Rosenfeld M.G., Glass C.K. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 2001, 276:36865-36868.
48. Naar A.M., Lemon B.D., Tjian R. Transcriptional coactivator complexes. Annu Rev Biochem 2001, 70:475-501.
49. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
50. Li J., Wang J., Nawaz Z., Liu J.M., Qin J., Wong J. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 2000, 19:4342-4350.
51. Guenther M.G., Lane W.S., Fischle W., Verdin E., Lazar M.A., Shiekhattar R. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev 2000, 14:1048-1057.
52. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 2003, 983:84-100.
53. Brandl A., Heinzel T., Kramer O.H. Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell 2009, 101:193-205.
54. Jones D.R., Divecha N. Linking lipids to chromatin. Curr Opin Genet Dev 2004, 14:196-202.
55. Jansen M.S., Nagel S.C., Miranda P.J., Lobenhofer E.K., Afshari C.A., McDonnell D.P. Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci U S A 2004, 101:7199-7204.
56. Arakawa R., Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem 2002, 277:22426-22429.
57. Oram J.F., Lawn R.M., Garvin M.R., Wade D.P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000, 275:34508-34511.
58. Parks J.S., Rudel L.L. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis 1990, 84:83-94.
59. Demaison L., Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 2002, 59:463-477.
60. Schaefer E.J. Effects of dietary fatty acids on lipoproteins and cardiovascular disease risk: summary. Am J Clin Nutr 1997, 65:1655S-1656S.
61. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.